European equities traded in the US as American depositary receipts were trending slightly lower late Monday morning, declining 0.16% to 1,278.01 on the S&P Europe Select ADR Index. From continental ...

Truist Financial analyst Joon Lee assigned a Buy rating to the stock today. The company’s shares closed last Friday at $42.02.Don't Miss Our ...

4. Verona’s Ohtuvayre (ensifentrine) for COPD Just as Verona Pharma secured the FDA nod to market inhalable COPD drug Ohtuvayre in June, its commercial prospects seemed to improve markedly. While ...

European equities traded in the US as American depositary receipts started the week off higher late Monday morning, rising 0.32% to 1,343.34 on the S&P Europe Select ADR Index. From continental Europe ...

Centiva Capital LP lowered its stake in shares of Verona Pharma plc (NASDAQ:VRNA – Free Report) by 37.4% in the third quarter ...

Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Basic Materials, Utilities and Financials sectors propelled shares lower. At the close in NYSE,... Investing.com – U ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.